Research Output

Filter
Editorial
2020

DNA Repair and Prostate Cancer: A Field Ripe for Harvest

Bryce, A. H., Sartor, O. & de Bono, J., 2020, (Accepted/In press) In : European urology.

Research output: Contribution to journalEditorial

2018

Need for consensus statement for cholangiocarcinoma diagnosis, prognostication and treatment: An IASGO initiative

Rahbari, N. N., Duda, D. G., Borad, M. J. & Han, H. S., Aug 2018, In : Surgery, Gastroenterology and Oncology. 23, 4, p. 217-218 2 p.

Research output: Contribution to journalEditorial

Stereotactic body radiotherapy for early-stage non-small cell lung cancer has low post-treatment mortality

Niska, J. R., Sio, T. T., Daniels, T. B., Beamer, S. E., Jaroszewski, D. E., Ross, H. J., Paripati, H. R. & Schild, S. E., Jun 1 2018, In : Journal of Thoracic Disease. 10, p. S2004-S2006

Research output: Contribution to journalEditorial

2017

Maintenance lenalidomide after transplantation in multiple myeloma prolongs survival—in most

Mikhael, J. R., Oct 10 2017, In : Journal of Clinical Oncology. 35, 29, p. 3269-3271 3 p.

Research output: Contribution to journalEditorial

3 Scopus citations
2016

Taking aim at the genomic diversity of gastrointestinal cancers: A changing landscape

Bekaii-Saab, T. & El-Rayes, B., Jan 1 2016, In : Journal of Gastrointestinal Oncology. 7, 5, p. 673-674 2 p.

Research output: Contribution to journalEditorial

2015

Therapeutic advances in pancreatic cancer: Miles to go before we sleep

Bekaii-Saab, T. & Goldberg, R., Feb 1 2015, In : Journal of the National Cancer Institute. 107, 2, dju439.

Research output: Contribution to journalEditorial

4 Scopus citations
2014

Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms

Mughal, T. I., Vannucchi, A. M., Soverini, S., Bazeos, A., Tibes, R., Saglio, G., Abdel-Wahab, O., Pardanani, A., Hehlmann, R., Barbui, T., Van Etten, R., Tefferi, A. & Goldman, J. M., May 1 2014, In : Haematologica. 99, 5, p. 797-801 5 p.

Research output: Contribution to journalEditorial

4 Scopus citations

Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials

Mascarenhas, J., Mesa, R., Prchal, J. & Hoffman, R., Jun 1 2014, In : Haematologica. 99, 6, p. 945-949 5 p.

Research output: Contribution to journalEditorial

20 Scopus citations
2013

Consultative Hematology: Introduction

Noel, P., Jul 1 2013, In : Seminars in Hematology. 50, 3, 1 p.

Research output: Contribution to journalEditorial

Jak inhibitors: Beyond spleen and symptoms?

Cervantes, F., Mesa, R. & Harrison, C., Feb 1 2013, In : Haematologica. 98, 2, p. 160-162 3 p.

Research output: Contribution to journalEditorial

9 Scopus citations
2012

JAK inhibition: The key to treating myeloproliferative neoplasm?

Tibes, R., Bogenberger, J. M. & Mesa, R. A., Dec 1 2012, In : Expert Review of Hematology. 5, 6, p. 583-585 3 p.

Research output: Contribution to journalEditorial

MPN blast phase: Clinical challenge and assessing response

Mesa, R. A. & Tibes, R., Dec 1 2012, In : Leukemia Research. 36, 12, p. 1496-1497 2 p.

Research output: Contribution to journalEditorial

5 Scopus citations
2011

Transplantation for myelofibrosis: Time for a randomized trial

Mesa, R. A., Aug 1 2011, In : Leukemia Research. 35, 8, p. 987-988 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations
2010

APOE ε2 and presymptomatic stage Alzheimer disease: How much is not enough?

Caselli, R. J. & Dueck, A. C., Nov 30 2010, In : Neurology. 75, 22, p. 1952-1953 2 p.

Research output: Contribution to journalEditorial

2 Scopus citations

Detangling fibrosis assessment in MPNs

Mesa, R. A., Jul 1 2010, In : Leukemia Research. 34, 7, p. 854-855 2 p.

Research output: Contribution to journalEditorial

2008
15 Scopus citations

Clinically relevant end points and new drug approvals for myeloma

Anderson, K. C., Kyle, R. A., Rajkumar, S. V., Stewart, A. K., Weber, D. & Richardson, P., Feb 2008, In : Leukemia. 22, 2, p. 231-239 9 p.

Research output: Contribution to journalEditorial

135 Scopus citations
2007

The dawn of targeted therapy for primary myelofibrosis: Opportunities and challenges

Mesa, R. A., Jul 1 2007, In : Leukemia Research. 31, 7, p. 883-886 4 p.

Research output: Contribution to journalEditorial

2006

Relapse of acute promyelocytic leukemia with PML-RARα mutant subclones independent of proximate all-trans retinoic acid selection pressure

Gallagher, R. E., Schachter-Tokarz, E. L., Zhou, D. C., Ding, W., Kim, S. H., Sankoorikal, B. J., Bi, W., Livak, K. J., Slack, J. L. & Willman, C. L., Apr 2006, In : Leukemia. 20, 4, p. 556-562 7 p.

Research output: Contribution to journalEditorial

21 Scopus citations
2005

Hepatic B-cell non-Hodgkin's lymphoma of MALT type in the liver explant of a patient with chronic hepatitis C infection

Orrego, M., Guo, L., Reeder, C., De Petris, G., Balan, V., Douglas, D. D., Byrne, T., Harrison, E., Mulligan, D., Rodriguez-Luna, H., Moss, A., Reddy, K., Rakela, J. & Vargas, H. E., Jul 1 2005, In : Liver Transplantation. 11, 7, p. 796-799 4 p.

Research output: Contribution to journalEditorial

9 Scopus citations
2003

Allogeneic stem cell transplantation for chronic myeloproliferative disorders and myelodysplastic syndromes: The question is "when?"

Maziarz, R. T., Mesa, R. A. & Tefferi, A., Aug 1 2003, In : Mayo Clinic proceedings. 78, 8, p. 941-943 3 p.

Research output: Contribution to journalEditorial

Open Access
11 Scopus citations

Prognostic factors in multiple myeloma: It's in the genes

Bergsagel, P. L., Feb 1 2003, In : Clinical Cancer Research. 9, 2, p. 533-534 2 p.

Research output: Contribution to journalEditorial

9 Scopus citations
2001

Tumor-Dendritic Cell Fusion Technology and Immunotherapy Strategies

Shu, S. & Cohen, P., Jan 1 2001, In : Journal of Immunotherapy. 24, 2, p. 99-100 2 p.

Research output: Contribution to journalEditorial

20 Scopus citations